Skip to main content
SpringerLink
Log in

Inter-organ/cellular Communication and Microenvironment of Digestive Cancer

Participating journal: Discover Oncology

The fate of tumor cells depend on the outcome of their interaction with peripheral tissues, immune system, microbes and even distant organs. Many signal molecules or particles, including exosomes and cytokines, are involved, and their excessive or inappropriate release in the microenvironment and circulation leads to digestive cancer progression. Deciphering the signaling pathways and candidate targets can facilitate the early diagnosis, recurrence monitoring and precise treatment for digestive cancer patients.

keywords: Digestive cancer; Cancer metabolism; Cancer immunology; Inflammation; Tumor microenvironment; Cancer cachexia; Sarcopenia; Gut microbes

Participating journal

Discover Oncology

Journal

Discover Oncology

Discover Oncology is an open access journal publishing content that interfaces at all levels of cancer research.

Publishing model
Open access
Journal Impact Factor
2.8 (2023)
Downloads
614.4k (2023)
Submission to first decision (median)
14 days

Editors

  • Xiao Xu

    Professor, Zhejiang University School of Medicine, China. He is the President of Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine. He is the Yangtze River Scholar Distinguished Professor of the Ministry of Education, winner of the National Science Fund for Distinguished Young Scholars, winner of Ten Thousand Talent Program and Qiushi Distinguished Professor of Zhejiang University.

  • Lixing Zhan

    Professor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, China. She currently is the Professor and Principal Investigator in the Laboratory of Cell Polarity & Cancer Metabolism, Shanghai Institute of Nutrition and Health (SINH), Chinese Academy of Sciences.

  • Zhao Li

    PhD, Peking University People’s Hospital, China. He is a hepatobiliary surgeon at the Department of Hepatobiliary Surgery, Peking University People’s Hospital (PKUHSC). He specializes in the surgical treatment of primary liver cancer, including liver transplantation and liver resection. His main research interests lie in the molecular mechanisms that drive metastasis and recurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma, especially focusing on tumor immune microenvironment.

Articles

Showing 1-7 of 7 articles

Search

Navigation